News
The board of directors of Eli Lilly and Company (NYSE:LLY) has declared a dividend for the second quarter of 2025 of $1.50 ...
Vertex Pharmaceuticals should continue to beat the market. Any time is a great time to buy stocks -- if you pick the right ...
4h
Zacks Investment Research on MSNInvestors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to KnowEli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...
Plus, the National Academy of Sciences received $20 million, Agnes Scott College got $15 million, and three other ...
14h
WISH-TV on MSNAer Lingus flight marks new connection between Indianapolis and DublinThe first nonstop Aer Lingus flight from Dublin, Ireland landed Saturday night, but the long-term impact is just starting to take off.
Our writer explains why he just added to a big loser to his Stocks and Shares ISA portfolio, despite it going against one of ...
The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...
3h
Zacks Investment Research on MSN5 Drug/Biotech Stocks Likely to Outperform Q1 Earnings EstimatesThe first-quarter earnings season for the Medical sector will be in full swing this week as several drugmakers are slated to ...
These three stocks could potentially help investors create a stable – and growing – stream of passive income in the years ...
The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.
Key points A 28-year-old man with cocaine and alcohol use disorders presented to the emergency department with a 2-month history of worsening shortness of breath, orthopnea, and fatigue. His medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results